Comparing left bundle branch pacing to standard right ventricular pacing
Official title: LEFT Bundle Pacing vs Standard Right Ventricular Pacing for Heart Failure
Run by McGill University Health Centre/Research Institute of the McGill University Health Centre · NCT05015660 · Data updated 2026-11-12
This study tests if a new way of pacing the heart called left bundle branch pacing can help people with a serious heart condition live longer and feel better compared to the standard pacing method.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1300 (estimated) |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre Academic / other |
| Locations | 1 site (Montreal, Quebec) |
| Status | Recruiting |
| Started | September 1, 2022 |
| Main results expected | December 1, 2026 |
| Study ends | January 1, 2030 |
| Registry record updated | March 11, 2026 |
| Trial ID | NCT05015660 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with an ejection fraction greater than 35% and high-degree AV block requiring more than 90% ventricular pacing.
✕Probably not a fit
Patients who may not benefit include those with indications for an implantable cardioverter defibrillator or other serious medical conditions with a life expectancy of less than two years.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of left bundle branch pacing (LBBP) compared to standard right ventricular pacing (RVP) in patients with high-degree atrioventricular block. The study aims to determine if LBBP can reduce cardiovascular death, heart failure events, and changes in left ventricular size over time. Patients will undergo echocardiograms and NTproBNP tests at various intervals to monitor their heart function and health outcomes. The trial focuses on individuals who are expected to require significant ventricular pacing due to their heart condition.
Why it matters
Potential benefit: If successful, this approach could lead to improved heart function and reduced cardiovascular risks for patients requiring pacemakers.
How similar studies have gone: While the approach of left bundle branch pacing is emerging, it is still relatively novel and has not been extensively tested in large-scale studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Patients with an ejection fraction of \>35% 3. Patients with an indication for ventricular pacing and high-degree atrioventricular block where the degree of anticipated RV pacing is \>90% including: 1. Third degree AV block 2. Symptomatic or asymptomatic second-degree AV block 3. First degree AV block ≥ 280ms with a narrow QRS, or ≥ 240ms with an intraventricular delay (QRS duration ≥120ms) 4. Echocardiogram within the last 3 months, with ability to have DICOM images Exclusion Criteria: 1. Indication for an implantable cardioverter defibrillator 2. Presence of a mechanical tricuspid valve 3. Any prior attempt at implantation of an ICD, CRT, HBP, or LBBP 4. Lack of capacity to consent 5. Other serious medical condition with life expectancy of \<2 years 6. Pregnancy 7. Patients in whom the conduction system abnormality is expected to be transient or recover over time 8. Patients with permanent atrial fibrillation
Where it's running
-
McGill University Health Centre-Research Institute
Montreal, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Jacqueline Joza, MD MSc
- Email: jacqueline.joza@gmail.com
- Phone: 514-934-1934
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can fluoroscopy plus TTE guidance improve leadless pacemaker placement accuracy
This study tests whether using transthoracic echocardiography (TTE) during leadless pacemaker placement improves accuracy and safety compared with standard fluoroscopy.
-
Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing
This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.
-
Mapping the Left Bundle Branch Area for Pacemaker Placement
This study is testing how using 3D mapping technology during pacemaker placement can help doctors understand the heart's Left Bundle Branch Area better and improve the success of the procedure for patients.
-
Evaluating a non-invasive method for cardiac resynchronization therapy
This study tests a new non-invasive device to see how well cardiac resynchronization therapy works for people with heart failure and left bundle branch block during their treatment.
-
Evaluating new pacing methods for heart rhythm management
This study is testing new pacing methods for heart rhythm management to see if they work better and are safer for patients who need a pacemaker or ICD.
-
Database for predicting atrial fibrillation in patients with pacemakers and ICDs
This study is trying to see if data from patients with pacemakers or defibrillators can help predict the chances of them developing atrial fibrillation over six months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.